Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.6K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K
Exon Recombination02:32

Exon Recombination

4.3K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying circulating protein targets for common factors underlying schizophrenia, depression, and bipolar disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Probiotic-Derived CpG-DNA Enhances Food Allergy Immunotherapy via TLR9-Dependent Breg Induction and IL-10 Epigenetic Activation.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Screening and identification of Kringle 5-inhibitory microRNAs from Astragali radix decoction pieces using immobilized magnetic beads.

International journal of biological macromolecules·2026
Same author

Spatial transcriptomics identifies fibroblast-T cell crosstalk as a driver of Th2 polarization in allergic rhinitis.

Frontiers in immunology·2026
Same author

Novel Pathway for Intercepting Granular Exocytosis: A13 Engages APLNR to Drive FBXO28-Mediated Ubiquitination and Proteasomal Clearance of Rab27a in Allergic Inflammation.

Immunology·2026
Same author

Differentiating walled-off pancreatic necrosis with no documented pancreatitis from mucinous cystic neoplasms: a multicenter LASSO-based nomogram.

BMC gastroenterology·2026

Related Experiment Video

Updated: Mar 19, 2026

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
07:52

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation

Published on: July 23, 2012

15.5K

Dectin-1 epigenetic reprogramming rescues senescent-like Treg function in allergic asthma.

Xiangdong Sun1,2, Jiaqi Duan3, Le Liu3

  • 1Institute of Rehabilitation Medicine, Henan Academy of Innovations in Medical Science, Zhengzhou, China.

Life Science Alliance
|March 17, 2026
PubMed
Summary

New treatment KQS-1 reverses regulatory T-cell (Treg) dysfunction in allergic asthma by restoring immune balance. This approach enhances Treg function and reduces airway inflammation, offering a promising therapeutic avenue.

More Related Videos

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

16.5K
Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
10:25

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

7.5K

Related Experiment Videos

Last Updated: Mar 19, 2026

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
07:52

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation

Published on: July 23, 2012

15.5K
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

16.5K
Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
10:25

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

7.5K

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Allergic asthma involves immune dysregulation and impaired regulatory T-cell (Treg) function.
  • Mechanisms underlying Treg impairment and therapeutic correction are not fully understood.

Purpose of the Study:

  • To investigate the mechanisms of Treg dysfunction in allergic asthma.
  • To evaluate the therapeutic potential of KQS-1 in restoring Treg function and ameliorating asthma symptoms.

Main Methods:

  • Analysis of Treg senescence markers (telomere length, SA-β-gal activity, apoptosis) in patients.
  • Assessment of Treg suppressive capacity and cytokine profiles.
  • Investigation of KQS-1 effects on Treg function, gene expression (FOXP3, IL-10), signaling pathways (Raf-1/ROS), and epigenetic modifications (H3K4me3, H3K27ac).
  • Validation in mouse models of allergic asthma and adoptive transfer experiments.

Main Results:

  • Patient Tregs exhibited senescence, reduced suppressive capacity, and a pro-inflammatory cytokine shift.
  • KQS-1 treatment restored Treg suppressive function and anti-inflammatory cytokine production.
  • Functional rescue was dependent on Dectin-1 binding and a Raf-1/ROS signaling axis, leading to epigenetic changes at FOXP3 and IL10 loci.
  • CRISPR-mediated Dectin-1 deletion abolished KQS-1 effects.
  • KQS-1 treatment attenuated airway hyperresponsiveness, inflammation, and remodeling in mouse models.

Conclusions:

  • Treg senescence and dysfunction are key features of allergic asthma.
  • KQS-1 effectively restores Treg function through Dectin-1, Raf-1/ROS signaling, and epigenetic remodeling.
  • KQS-1 demonstrates therapeutic potential for allergic asthma by improving Treg function and reducing airway pathology.